DRKS00025222已完成不适用
Cellfree DNA as a prognostic biomarker in ICU patients suffering from COVID-19 or sepsis - COVSEP
Klinik für Anästhesiologie der Universitätsmedizin Mainz0 个研究点目标入组 64 人开始时间: 2021年4月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients who meet the following criteria will be included in this study:
- •-Patients =18 years of age with one of the three following diagnoses:
- •- Acute SARS-Cov-2 infection upon admission to the intensive care unit OR
- •- Sepsis with no known previous SARS-CoV-2 infection
排除标准
- •Patients who meet only one of the following criteria will not be included in this study:
- •- Pregnant women
- •- Breastfeeding women
- •- Known, active tumor disease in treatment
- •- Palliative therapy approach
- •- Present DNR (Do Not Resuscitate) / DNI (Do Not Intubate) / DNARRT (Do Not Apply Renal Replacement Therapy) arrangement
- •- Inclusion stop at escalation level 4 according to SOP of the COVID supply
研究者
相似试验
已完成
不适用
Cell-free DNA as a prognostic biomarker in patients with COVID-19 diseasecfDNA in patients with COVID-19DRKS00031641niversitätsmedizin Mainz72
招募中
不适用
Biomarker study using cell free DNA in patients with gastric canceradvanced gastric cancerJPRN-UMIN000014209Kindai University Faculty of Medicine
招募中
不适用
Biomarker study using cell free DNA in patients with colorectal canceradvanced colorectal cancerJPRN-UMIN000017966Kindai University Faculty of Medicine160
尚未招募
不适用
Clinical validation of circulating cell free DNA [ccfDNA] as a biomarker of metabolic healthObesityACTRN12622001326785Commonwealth Scientific and Industrial Research Organisation100
招募中
不适用
Biomarker study using cell-free DNA from patients with advanced breast canceradvanced breast cancerJPRN-UMIN000012881Kinki University Faculty of Medicine100